Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.17M | $104.0M | 8.52% | -- | 2026-03-31 |
| BlackRock, Inc. | 6.16M | $90.0M | 7.33% | +1.10M | 2026-03-31 |
| STATE STREET CORP | 3.57M | $52.0M | 4.24% | +777.8K | 2026-03-31 |
| ADAMS STREET PARTNERS LLC | 3.28M | $47.0M | 3.90% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.23M | $47.0M | 3.85% | -- | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.92M | $42.0M | 3.47% | +2.88M | 2026-03-31 |
| Vivo Capital, LLC | 2.81M | $41.0M | 3.34% | +571.3K | 2026-03-31 |
| MORGAN STANLEY | 2.50M | $36.0M | 2.97% | -1.07M | 2026-03-31 |
| Deep Track Capital, LP | 2.49M | $36.0M | 2.96% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.32M | $33.0M | 2.76% | +2.00M | 2026-03-31 |
